Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2018 Feb 15;45(8):1372–1381. doi: 10.1007/s00259-018-3941-3

Figure 2.

Figure 2

PET maximum intensity projection (MIP) images of Ramos and HBL-1 lymphoma tumor bearing models from 6 to 120 h post-injection. Following injection of 89Zr-Df-daratumumab, Ramos tumors displayed higher uptake than HBL-1 tumors at all time points. After injection of a 89Zr-Df-IgG, Ramos tumors demonstrated significantly decreased uptake at the same time points. Tumors are indicated by dashed circles.